Stockreport

PainReform cut to Hold at Maxim amid ‘changed' market dynamics [Yahoo! Finance]

PainReform Ltd. - Ordinary Shares  (PRFX) 
PDF The company is developing PRF-110 to treat post-operative pain and compete in the market with Exparel and Zynrelef, but market dynamics have recently changed, with a gen [Read more]